How did ACB's Q2 2025 EPS forecast compare to past trends?

Aurora Cannabis Inc.'s (ACB) Q2 2025 EPS forecast is not currently available, and it is difficult to compare to past trends without specific data. However, we can analyze the company's historical EPS performance and compare it to the forecasted Q2 2025 EPS. 1. **Historical EPS Performance**: - ACB's EPS in Q2 2025 was CA$0.05, which is a significant improvement from the CA$0.048 in Q2 2024. - The company's EPS in Q3 2025 was CA$0.57, up from a loss of CA$0.51 in Q3 2024. 2. **Comparison to Forecasted Q2 2025 EPS**: - The forecasted Q2 2025 EPS is not provided, so we cannot directly compare it to the historical performance. - However, the historical trend of improving EPS suggests that the forecasted Q2 2025 EPS could be positive, potentially higher than the CA$0.05 achieved in Q2 2025 if the company continues to improve. 3. **Market Conditions and Future Outlook**: - The cannabis industry has faced challenging market conditions, including tariffs on Canadian cannabis exports to the United States. - Despite these challenges, ACB has shown improvements in revenue and net income, with a revenue of CA$88.2 million in Q3 2025, up 37% from Q3 2024, indicating a positive growth trajectory that could influence the Q2 2025 EPS. 4. **Investor Considerations**: - Investors should consider the company's operational improvements, market conditions, and the potential impact on future EPS. - The forecasted Q2 2025 EPS should be evaluated in the context of the company's overall financial health and industry trends. In conclusion, while the exact comparison is not possible without the Q2 2025 EPS forecast, the historical trend of improving EPS for ACB suggests that the forecasted Q2 2025 EPS may be positive, potentially higher than the CA$0.05 achieved in Q2 2025.